FemousTechno6: Femoral Venous Pulsatility and Right Heart Dysfunction in Heart Surgery: An Observational Study

Sponsor
Montreal Heart Institute (Other)
Overall Status
Recruiting
CT.gov ID
NCT05038267
Collaborator
Olivier Lachance, MD (Other), Melissa Parent, MD (Other), Patrick Tawil, MD (Other), Etienne Couture, MD PhD (Other), William Beaubien Souligny, MD PhD (Other), Yoan Lamarche, MD PhD (Other), Alexander Calderone (Other), Stephanie Jarry, MSc (Other), Ali Hammoud, RN (Other), Pierre Robillard, MD (Other), Olivier Royer, MD (Other), Elena Saade, MD (Other)
150
1
12
12.5

Study Details

Study Description

Brief Summary

Right heart failure during cardiac surgery is associated with increased perioperative morbidity and mortality. In this context, it is imperative to develop simple diagnostic tools to detect right heart failure. The purpose of this observational study is to determine if ultrasound Doppler of the femoral vein can detect and predict right ventricular failure after cardiac surgeries requiring cardiopulmonary bypass. It is expected that an elevated pulsatility of the femoral vein before the induction of general anesthesia is associated with perioperative right heart failure.

Study Design

Study Type:
Observational
Anticipated Enrollment :
150 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Femoral Venous Pulsatility and Right Heart Dysfunction in Heart Surgery: An Observational Study
Actual Study Start Date :
Aug 30, 2021
Anticipated Primary Completion Date :
Aug 30, 2022
Anticipated Study Completion Date :
Aug 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Femous patients

Adults undergoing general anesthesia for an elective cardiac surgery requiring cardiopulmonary bypass

Outcome Measures

Primary Outcome Measures

  1. Determine the prevalence of an elevated pulsatility of the femoral vein on Doppler ultrasound before the induction of general anesthesia [Before induction of anesthesia to day 1 postoperatively at the intensive care unit]

    An elevated pulsatility on Doppler ultrasound is defined as a biphasic signal of the femoral vein with a retrograde velocity > 10 cm/s on a long axis view at an angle correction < 60 degrees. If there's signs of cardiac modulation on the Doppler ultrasound, pulsatility index will be measured in long and short axis as followed : (maximal velocity - minimal velocity)/maximal velocity.

Secondary Outcome Measures

  1. Determine the association between an elevated femoral vein pulsatility and diastolic or systolic right ventricular failure, before and after cardiac surgery and at the intensive care unit [Before induction of anesthesia to day 1 postoperatively at the intensive care unit]

  2. Determine the association between an elevated femoral vein pulsatility and the intracardiac pressures of the right heart cavities and the pulmonary artery [Before induction of anesthesia to day 1 postoperatively at the intensive care unit]

  3. Determine the association between the prevalence of an elevated femoral vein pulsatility and the portal vein pulsatility [Before induction of anesthesia to day 1 postoperatively at the intensive care unit]

  4. Determine the impact of positive-pressure ventilation on the femoral vein pulsatility [After induction of anesthesia and before cardiopulmonary bypass.]

  5. Determine the association between a preoperative elevated femoral vein pulsatility and postoperative complications. [Immediate postoperative to Day 1 postoperatively at the intensive care unit]

    Postoperative complications will be defined as prolonged mechanical ventilation, inotropes or vasopressors dependencies, surgical second-look, acute kidney injury, mortality, hemorrhage, surgical sites infections, delirium and strokes

  6. Compare right and left femoral vein Doppler's ultrasound [Before induction of anesthesia to day 1 postoperatively at the intensive care unit]

  7. Determine the most valid measure between long and short axis ultrasound of the femoral vein, and their respective sensibility and specificity to predict complications [Before induction of anesthesia to day 1 postoperatively at the intensive care unit]

  8. Determine the sensibility and specificity of the values obtained by the femoral vein Doppler ultrasound to predict postoperative complications [Before induction of anesthesia to day 1 postoperatively at the intensive care unit]

  9. Determine if the diameter of the femoral vein as a useful predictor of right heart failure or of post-operative complications [Before induction of anesthesia to day 1 postoperatively at the intensive care unit]

  10. Determine the association between an elevated femoral vein pulsatility and postoperative delirium (as evaluated by the Intensive Care Delirium Screening Checklist) [Before induction of anesthesia to day 1 postoperatively at the intensive care unit]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults (at least 18 years old)

  • Able to consent

  • Undergoing elective cardiac surgery at the Montreal Heart Institute

  • Surgery requiring cardiopulmonary bypass

  • Peri-operative trans-oesophageal echography planned

Exclusion Criteria:
  • Critical preoperative state, defined as vasopressor requirement, mechanical support including intra-aortic balloon, mechanical ventilation or cardiac arrest necessitating resuscitation

  • Know condition that could interfere with femoral venous assessment or interpretation (such as femoral vein thrombosis, femoral instrumentation, ECMO, etc.)

  • Planned cardiac transplantation, implantation of a ventricular assist device or surgery for a congenital condition

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Montreal Heart Institute Montreal Quebec Canada H1T 1C8

Sponsors and Collaborators

  • Montreal Heart Institute
  • Olivier Lachance, MD
  • Melissa Parent, MD
  • Patrick Tawil, MD
  • Etienne Couture, MD PhD
  • William Beaubien Souligny, MD PhD
  • Yoan Lamarche, MD PhD
  • Alexander Calderone
  • Stephanie Jarry, MSc
  • Ali Hammoud, RN
  • Pierre Robillard, MD
  • Olivier Royer, MD
  • Elena Saade, MD

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Andre Denault, MD, PhD, FRCPC, ABIM-CCM, Montreal Heart Institute
ClinicalTrials.gov Identifier:
NCT05038267
Other Study ID Numbers:
  • ICM # 2021-2963
First Posted:
Sep 9, 2021
Last Update Posted:
Sep 9, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Andre Denault, MD, PhD, FRCPC, ABIM-CCM, Montreal Heart Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 9, 2021